Decision: Favourable
Study Title:
Clinical Performance Study for the Signatera Test Used in Identification of Circulating Tumor-DNA in Muscle-Invasive Bladder Cancer Patients Enrolled Under F. Hoffmann-La Roche Clinical Study Protocol BO42843
NREC Code:
23-NREC-MD-031
Decision:
Favourable
Meeting Date:
16/11/2023
Study Type:
MD Application
Principal Investigator:
Prof. Ray McDermott
PI Institution:
Tallaght University Hospital
Sponsor:
F.Hoffmann La-Roche Ltd.